Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1124901

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nusinersen
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza.
tabling member printed	Baroness Thomas of Winchester
uin	HL15576
answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15577 question first answered 17/05/2019 11:07:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124902

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March.
tabling member printed	Baroness Thomas of Winchester
uin	HL15577
answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15576 question first answered 17/05/2019 11:07:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124923

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Infectious Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231466 on Hospitals: Infectious Diseases, whether work of Public Health England will also include as assessment of the effect of changes to ophthalmic surgical practice on trends in the level of risk of infection rates in hospitals.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	251326
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>Public Health England does not currently include ophthalmic surgery as part of mandatory or voluntary surveillance of surgical site infections.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/05/2019 16:24:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1124924

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ophthalmic Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231467 on Ophthalmic Services, whether he has made an assessment of the ability for clinicians to take into account patients’ wishes for concomitant treatment in relation to potential restrictions of the 2019/2020 NHS Tariff.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	251327
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>For the 2017/19 national tariff (which was set for two years), the prices for BZ91 were manually increased above the initially modelled level (based on 2014/15 reference costs) following feedback from the ophthalmology Expert Working Group (EWG). For 2019/20, the EWG recommended that the prices for BZ91 should not be increased and should remain as modelled (based on 2016/17 reference costs).</p><p>The EWG also confirmed that minimally invasive glaucoma surgery (MIGS) and cataract activity are commonly done together and it would not usually be in the patient’s best interest to do them separately. The EWG advised that BZ91 was appropriate for combined MIGS and cataract activity – a MIGS procedure plus a cataract procedure should not receive over twice as much as either procedure alone.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/05/2019 16:43:32 answering member 4455 label Biography information for Seema Kennedy
tabling member	4131 label Biography information for Jim Shannon

1124938

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Education: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department is making on producing a public information campaign to educate the general public on the health impacts of air pollution, particularly in instances of moderate or high pollution episodes.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	251250
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>Public Health England and the Department for Environment, Food and Rural Affairs (Defra) are exploring whether social marketing can assist in awareness-raising about air pollution.</p><p>The Joint Air Quality Unit (JAQU) is planning a national-level campaign to support Clean Air Zones (CAZ) from summer 2019. This will raise awareness of the risks presented by high concentrations of nitrogen dioxide (NO2) and the implementation of charging CAZ. It will also promote long-term behaviour change by encouraging the public to change travel habits and reduce NO2 emissions.</p><p>The JAQU has also provided a CAZ communications toolkit to support local authorities in their local communications work. It contains key messages, frequently asked questions, useful statistics, infographics and other content to ensure a consistent approach is taken to raising awareness and to encourage drivers to consider alternative options in terms of travel and vehicle choice.</p><p>Defra is developing a communication strategy on domestic combustion for launch before the next winter burning season.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/05/2019 16:30:01 answering member 4455 label Biography information for Seema Kennedy
tabling member	1564 label Biography information for Angela Smith

1124974

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Phenylketonuria: Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the NICE appraisal of Kuvan will consider the increased prevalence of neuropsychiatric comorbidities in adults with phenylketonuria.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251357
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>In developing its recommendations on Kuvan, the National Institute for Health and Care Excellence (NICE) will consider all the health-related costs and benefits associated with the treatment in accordance with its published methods and processes and the scope for the appraisal that has been developed in consultation with stakeholders; potentially including any costs from National Health Service funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251358 question first answered 15/05/2019 16:31:51 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill

1124975

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 November 2018 to Question 190518 on Sapropterin, whether the NICE appraisal of Kuvan will take into account the costs from NHS funded treatments that can be avoided such as food supplements.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251358
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>In developing its recommendations on Kuvan, the National Institute for Health and Care Excellence (NICE) will consider all the health-related costs and benefits associated with the treatment in accordance with its published methods and processes and the scope for the appraisal that has been developed in consultation with stakeholders; potentially including any costs from National Health Service funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251357 question first answered 15/05/2019 16:31:51 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill

1125002

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternity Services: Vacancies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to address staff shortages in maternity units; and if he will make a statement.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	251226
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>Health Education England released its strategy to increase the numbers of staff working in maternity services within the Maternity Workforce Strategy. This can be found at the following link:</p><p><a href="https://www.hee.nhs.uk/our-work/maternity/maternity-workforce-transformation-strategy" target="_blank">https://www.hee.nhs.uk/our-work/maternity/maternity-workforce-transformation-strategy</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 15/05/2019 16:21:14 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1125045

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Mental Illness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of (a) identification and (b) treatment of perinatal mental illnesses; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	251267
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>The Department is committed to improving both the detection and treatment of perinatal mental illness.</p><p> </p><p>The Five Year Forward View for Mental Health committed to invest £365 million from 2015/16 to 2020/21 in perinatal mental health services to ensure that by 2020/21 at least 30,000 more women each year are able to access evidence-based specialist mental health care during the perinatal period.</p><p> </p><p>The NHS Long Term Plan, published in January 2019, includes a commitment for a further 24,000 women to be able to access specialist perinatal mental health care by 2023/24. Specialist care will also be available from preconception to 24 months after birth, which will provide an extra year of support. Support will also be extended to fathers and partners of women accessing specialist perinatal mental health services and maternity outreach clinics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 15/05/2019 16:38:49 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3930 label Biography information for Caroline Lucas

1125047

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce waiting times for children receiving initial mental health treatment in West Yorkshire.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	251238
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>Protecting our children’s mental health is a priority for this Government and a core part of the NHS Long Term Plan. The National Health Service has set a goal of an extra 345,000 children and young people, aged 0-25, receiving support via NHS-funded mental health services by 2023/24.</p><p> </p><p>Close to 325,000 children and young people have been treated through NHS commissioned community services in 2017/18. We are on track to deliver the Five Year Forward View for Mental Health’s commitment to improve care and extend access to 70,000 more children and young people by 2020/21.</p><p> </p><p>The recent ‘Transforming children and young people’s mental health provision: a Green Paper’ aims to improve provision of support for all children and young people through its three key proposals:</p><p>- Incentivising every school/college to identify and train Designated Senior Lead for Mental Health;</p><p>- Creating new Mental Health Support Teams in/around schools; and</p><p>- Piloting a four-week waiting time for specialist NHS services.</p><p> </p><p>Clinical commissioning groups in West Yorkshire are responsible for ensuring adequate access to mental health treatment locally.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 15/05/2019 16:26:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	411 label Biography information for Mr Barry Sheerman